How to Buy Immunovant Stock

Immunovant Inc

Immunovant, Inc. , a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.

Immunovant stock last closed at $26.98, up 1.39% from the previous day, and has decreased 3.33% in one year. It has overperformed other stocks in the Biotechnology industry by 0.38 percentage points. Immunovant stock is currently +112.11% from its 52-week low of $12.72, and -2.56% from its 52-week high of $27.69.

There are currently 175.28M shares of IMVT outstanding. The market capitalization of IMVT is $4.73B. In the last 24 hours, 2.67M IMVT shares were traded.

How to Buy Immunovant Stock

Not sure how to invest in Immunovant stock? Here's how.

  1. Choose where to buy Immunovant stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Immunovant stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Put funds into your investment account: Choose your payment method and add your details.
  4. Evaluate Immunovant stock: The Immunovant ticker symbol is IMVT. Is Immunovant stock a good investment? Should you buy shares of IMVT? How do IMVT's underlying business fundamentals look? Do top analysts think Immunovant is a good buy? Why has IMVT's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if IMVT is a good stock to buy).
  5. Make your IMVT trade: Decide if you will purchase IMVT shares at the current market price or use a limit order to buy IMVT stock at a specific price.
  6. Track your IMVT investment: Create a watchlist to get live updates on your new investment in Immunovant shares.

Step 1: Choose where to buy Immunovant stock

You will need an online brokerage account in order to access the NASDAQ market and buy IMVT stock.

A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our research, eToro is the best brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in IMVT today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to open a new brokerage account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've finished signing up on a investment app, your next step is to transfer the money for your investment:

Check out the tutorial below to see the process of depositing money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Immunovant stock

Once you have decided on the best place to buy Immunovant stock, it's absolutely critical to research their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.

Immunovant stock at a glance

IMVT Price
$26.98
1w %
14.52%
1y %
-3.33%
5y %
-47.66%
P/E
-9.53x
P/B
9.1x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$464.69M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$4.73B
Next Earnings
Feb 18, 2026
Next Dividend
N/A

Immunovant Due Diligence Score

WallStreetZen was designed to help part-time investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on IMVT's stock page.

Is IMVT stock undervalued?

You can use many financial metrics, analyses, models, and charts to gauge IMVT's fair value.

Using relative valuations methods:

  • IMVT may be overvalued based on its P/B ratio of 9.1x, relative to Biotechnology industry P/B ratio of 5.19x

You can do additional valuation analysis on IMVT's stock here.

IMVT Financial Health Overview

Passed Health Checks:

  • There are more short-term assets than long-term liabilities on the IMVT balance sheet.
  • IMVT has cash burn of 431335000. It has enough cash and short-term investments to cover this for at least one year.
  • IMVT has a low debt to equity ratio of 0.12.
  • There are more short-term assets than short-term liabilities on the IMVT balance sheet.

Failed Health Checks:

  • Total IMVT debt is higher than 5 years ago, relative to shareholder equity.
  • IMVT has $521.87M in cash and short term investments. This is not sufficient to cover its annual cash burn of $431.34M.

Is it a good time to buy IMVT stock, according to analysts?

Out of 6 Equities analysts who give recommendations on IMVT, the consensus analyst rating on Immunovant is a Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

Most Recent IMVT Analyst Ratings

Ashwani Verma, a top 14% analyst from UBS maintains IMVT with a hold rating and raises their IMVT price target from $17.00 to $18.00, on Jul 28, 2025.

You can dive deeper into what analysts are saying on the Immunovant stock forecast page.

IMVT Momentum

SMA10
24.61
SMA20
23.86
SMA50
22.16
SMA100
18.94
SMA200
17.64
MACD
1.09
MACD Signal
0.79
MACD Histogram
0.31
RSI
69.9
Stochastic %K
83.64
Stochastic %D
80.21
StochRSI %K
93.7
StochRSI %D
94.18

What are IMVT executives and large shareholders up to?

Over the past 12 months, executives and large shareholders at IMVT have bought more shares than they have sold.

Roivant Sciences Ltd, Director of IMVT, was the latest IMVT insider to buy. They bought $349,999,986.00 worth of IMVT shares on Dec 12, 2025.

Get more info about who owns IMVT stock here.

Can I get consistent income from IMVT stock?

No, Immunovant doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Make your IMVT trade

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are generally sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact dollar amount limit, place a limit order.

Click the Open Trade button and your broker will execute the order.

If you require additional help with buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Track your IMVT investment

Now that you own some shares in IMVT, you'll want to keep up with your company.

Start a watchlist to get the latest updates about your IMVT stock.

IMVT Feed

How to Buy Stock in Immunovant

To summarize, here are the 6 steps you need to take to buy Immunovant stock right now:

  1. Choose where to buy Immunovant stock
  2. Sign up for your brokerage account
  3. Put funds into your investment account
  4. Evaluate Immunovant stock
  5. Make your IMVT trade
  6. Track your IMVT investment

If you require a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your new investment in Immunovant, get started below.

NASDAQ: IMVT
$26.98+0.37 (+1.39%)
Updated Dec 17, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: IMVT
$26.98+0.37 (+1.39%)
Updated Dec 17, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Immunovant share?

As of Dec 17, 2025, it costs $26.98 to buy one share of Immunovant stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.371 shares of IMVT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Immunovant stock?

According to 6 Wall Street analysts who monitor Immunovant, their consensus recommendation is to buy Immunovant stock.

What is the best way to buy Immunovant stock?

One way to place an order for Immunovant stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.